DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

InterMune (NASDAQ: ITMN)

73.21 0.03 (0.04%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ITMN $73.21 0.04%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.13
Previous Close $73.18
Daily Range $73.13 - $73.44
52-Week Range $10.95 - $73.44
Market Cap $7.9B
P/E Ratio -28.15
Dividend (Yield) $0.00 (0.0%)
Volume 6,614,136
Average Daily Volume 4,898,260
Current FY EPS -$2.72

Sector

Healthcare

Industry

Drugs

InterMune (ITMN) Description

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website: http://www.intermune.com/

News & Commentary Rss Feed

Up 35% on Buyout: InterMune inc Investor Key Takeaways

FDA's rejection of InterMune's Esbriet hurt investors, but Roche clearly thinks the drug will be approved.

Markets Reverse Early Morning Losses; Still Lower On The Day

Benzinga's Top Initiations

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Bl

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

Roche, InterMune a Strategic Play in Midst of Inversions

Should you buy ISIS? No, not that one

Today In SA PRO: Tuesday, August 26

Roche Furthers Immunotherapy Program with SP142 Launch - Analyst Blog

With An Iffy Non-Oncology Pipeline, Roche Pays Up For InterMune

Biotech ETFs Surge on InterMune-Roche Deal - ETF News And Commentary

S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue To Rally

See More ITMN News...

ITMN's Top Competitors

ITMN $73.21 (0.04%)
Current stock: ITMN
AMGN $138.69 (0.62%)
Current stock: AMGN
GILD $107.51 (0.09%)
Current stock: GILD
BIIB $341.24 (-0.62%)
Current stock: BIIB